Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Dr. Jared Weiss is an Associate Professor of Clinical Research for Hematology/Oncology at the University of North Carolina School of Medicine in Chapel Hill, NC. He completed fellowship in Hematology and Oncology at the University of Pennsylvania and residency in Internal Medicine at Beth Israel Deaconess Medical Center in Boston, MA. He received his Doctor of Medicine at Yale University School of Medicine in New Haven, CT and his B.S. in neuroscience at Brown University, in Providence, RI.
Head and Neck Cancer Treatment Update: Pembrolizumab, Nivolumab and PD-L1 Markers
Drs. Jared Weiss, Assistant Professor, Clinical Research Hematology/Oncology, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, join GRACE to discuss updates relating to pembrolizumab, nivolumab and PD-L1 markers for head and neck cancers.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Video
In this series, Vernon Sondak, Chair of the Department of Cutaneous Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, and Fiorinda Muhaj, MD Anderson Cancer Center, discuss basal and squamous cell carcinoma, including diagnosis, treatment options, and skin cancer prevention.
To watch the complete playlist, click here.
Thanks to Regeneron and Daiichi-Sankyo.
Image
Video
En esta serie de videos, los oncólogos, Luis Raez, MD FASCO FACP; Estelamari Rodríguez, MD, MPH; Miguel González Velez, MD y Suraj Samtani, MD, presentan la información de tratamiento más actual y emergente sobre el cáncer de pulmón a pacientes y cuidadores en un formato de video conciso y fácil de entender.
Mira la serie completa aquí.
Article
Liquid biopsies are revolutionizing how doctors detect and treat cancer. Unlike traditional tissue biopsies, which require removing a piece of the tumor, liquid biopsies use a simple blood test to reveal vital genetic information about a patient’s cancer—often faster and with fewer complications.
While still used mainly in advanced lung cancer, liquid biopsies are poised to become a frontline tool across many cancer types in the coming years—offering a faster, less invasive path to precision care.
Online Community
Hi James Anthony, I'm so sorry you are going through this and so very young. It' s true that some people benefit for years with chemo and targeted therapies. With the...
Hi siigs, I'm sorry you're having health issues. They don't sound like pancoast tumor symptoms. A consult with a pulmonologist can help to understand your chest symptoms and work toward alleviating...
Hi Lonnie,
Yes, the info in last year's OncTalk was up to date at that moment. I think it would be well worth the watch along with videos in our 2025...
Recent Comments
Tomorrow Saturday, Oct. 25, 2025
By JanineT GRACE … on
Blood Cancers OncTalk-Live, Free, Learn Sat. Oct. 25
By JanineT GRACE … on